Stem Cell Banking Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Stem Cell Banking Market covers analysis by Source (Placental Stem Cells (PSCS), Dental Pulp-Derived Stem Cells (DPSCS), Bone Marrow-Derived Stem Cells (BMSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Human Embryo-Derived Stem Cells (HESCS), and Other Stem Cell Sources), Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Clinical Applications, Research Applications, and Personalized Banking Applications), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPBT00002082
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Stem Cell Banking Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

Stem cell banking or preservation is a combined process of extraction, processing and storage of stem cells, so that they may be used for treatment of various medical conditions in the future, when required. Stem cells have the amazing power to get transformed into any tissue or organ in the body. In recent days, stem cells are used to treat variety of life-threatening diseases such as blood and bone marrow diseases, blood cancers, and immune disorders among others.

The market of stem cell banking is anticipated to grow with a significant rate in the coming years, owing to factors such as, development of novel technologies for stem cell preservation and processing, and storage; growing awareness on the potential of stem cells for various therapeutic conditions. Moreover, increasing investments in stem cell research is also expected to propel the growth of the stem cell banking market across the globe. On other hand rising burden of major diseases and emerging economies are expected to offer significant growth opportunities for the players operating in stem cell banking market.

The “Global Stem Cell Banking Market Analysis to 2028” is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The stem cell banking market report aims to provide an overview of global stem cell banking market with detailed market segmentation by source, service type, application, and geography. The global stem cell banking market is expected to witness high growth during the forecast period. The stem cell banking market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global stem cell banking market is segmented on the basis of source, service type, and application. The source segment includes, placental stem cells (PSCS), dental pulp-derived stem cells (DPSCS), bone marrow-derived stem cells (BMSCS), adipose tissue-derived stem cells (ADSCS), human embryo-derived stem cells (HESCS), and other stem cell sources. Based on service type the market is segmented into, sample processing, sample analysis, sample preservation and storage, sample collection and transportation. Based on application, the market is segmented as, clinical applications, research applications, and personalized banking applications.

The stem cell banking market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stem cell banking market based on source, service type, and application. It also provides market size and forecast till 2028 for overall stem cell banking market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America region is accounted to hold a major share market share of stem cell banking market, owing to the well developed and established technologies in the field of stem cell collection and preservation, rapidly growing number of stem cell transplantation procedures, and increasing public preference for private stem cell banking over public stem cell banks. On the other hand, the Asia-Pacific region is expected to exhibit significant growth over the forecast period, with the majority of growth primarily driven by owing to rising birth rates coupled with increasing prevalence of birth defects, options of paying for stem banking in monthly instalments, and rising power of per capita expenditure on healthcare facilities in this region.

The stem cell banking market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The stem cell banking market report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The stem cell banking market report also includes the profiles of key companies engaged with stem cell banking along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Cordlife, ViaCord (A Subsidiary of PerkinElmer), Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell International, Inc., SMART CELLS PLUS, Vita 34, LifeCell, Global Cord Blood Corporation, CBR Systems, Inc.

REGIONAL FRAMEWORK

Stem Cell Banking Market Report Analysis

Stem Cell Banking Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Cordlife
  • ViaCord (A Subsidiary of PerkinElmer)
  • Cryo-Save AG
  • StemCyte India Therapeutics Pvt. Ltd.
  • Cryo-Cell International, Inc.
  • SMART CELLS PLUS.
  • Vita 34
  • LifeCell
  • Global Cord Blood Corporation

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Source
  • Placental Stem Cells
By Service Type
  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation
By Application
  • Clinical Applications
  • Research Applications
  • Personalized Banking Applications
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

Stem Cell Banking Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Source
  • Placental Stem Cells
By Service Type
  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation
By Application
  • Clinical Applications
  • Research Applications
  • Personalized Banking Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Cordlife
  • ViaCord (A Subsidiary of PerkinElmer)
  • Cryo-Save AG
  • StemCyte India Therapeutics Pvt. Ltd.
  • Cryo-Cell International, Inc.
  • SMART CELLS PLUS.
  • Vita 34
  • LifeCell
  • Global Cord Blood Corporation
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Cordlife
    2. ViaCord (A Subsidiary of PerkinElmer)
    3. Cryo-Save AG
    4. StemCyte India Therapeutics Pvt. Ltd.
    5. Cryo-Cell International, Inc.
    6. SMART CELLS PLUS.
    7. Vita 34
    8. LifeCell
    9. Global Cord Blood Corporation
    10. CBR Systems, Inc.

    Trends and growth analysis reports related to Biotechnology : READ MORE..